92 related articles for article (PubMed ID: 18236780)
41. Combination of β-cyclodextrin inclusion complex and self-microemulsifying drug delivery system for photostability and enhanced oral bioavailability of methotrexate: novel technique.
Bourkaib N; Zhou J; Yao J; Fang Z; Mezghrani O
Drug Dev Ind Pharm; 2013 Jun; 39(6):918-27. PubMed ID: 22998295
[TBL] [Abstract][Full Text] [Related]
42. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
[TBL] [Abstract][Full Text] [Related]
43. Beta-cyclodextrin reduces bioavailability of orally administered [3H]benzo[a]pyrene in the rat.
Westerberg G; Wiklund L
J Pharm Sci; 2005 Jan; 94(1):114-9. PubMed ID: 15761935
[TBL] [Abstract][Full Text] [Related]
44. Human-relevant concentrations of the antifungal drug clotrimazole disrupt maternal and fetal steroid hormone profiles in rats.
Draskau MK; Rosenmai AK; Scholze M; Pedersen M; Boberg J; Christiansen S; Svingen T
Toxicol Appl Pharmacol; 2021 Jul; 422():115554. PubMed ID: 33910022
[TBL] [Abstract][Full Text] [Related]
45. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
[TBL] [Abstract][Full Text] [Related]
46. Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin.
Ren K; Zhang Z; Li Y; Liu J; Zhao D; Zhao Y; Gong T
Pharmazie; 2009 Aug; 64(8):515-20. PubMed ID: 19746840
[TBL] [Abstract][Full Text] [Related]
47. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Wang S; Ding Y; Yao Y
Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873
[TBL] [Abstract][Full Text] [Related]
48. Cyclodextrin multicomponent complexation and controlled release delivery strategies to optimize the oral bioavailability of vinpocetine.
Ribeiro LS; Falcão AC; Patrício JA; Ferreira DC; Veiga FJ
J Pharm Sci; 2007 Aug; 96(8):2018-28. PubMed ID: 17530626
[TBL] [Abstract][Full Text] [Related]
49. In vitro and in vivo studies on the complexes of glipizide with water-soluble β-cyclodextrin-epichlorohydrin polymers.
Nie S; Zhang S; Pan W; Liu Y
Drug Dev Ind Pharm; 2011 May; 37(5):606-12. PubMed ID: 21469949
[TBL] [Abstract][Full Text] [Related]
50. Preliminary pharmacokinetic study of different preparations of acyclovir with beta-cyclodextrin.
Luengo J; Aránguiz T; Sepúlveda J; Hernández L; Von Plessing C
J Pharm Sci; 2002 Dec; 91(12):2593-8. PubMed ID: 12434403
[TBL] [Abstract][Full Text] [Related]
51. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
[TBL] [Abstract][Full Text] [Related]
52. Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique.
Li DX; Oh YK; Lim SJ; Kim JO; Yang HJ; Sung JH; Yong CS; Choi HG
Int J Pharm; 2008 May; 355(1-2):277-84. PubMed ID: 18243606
[TBL] [Abstract][Full Text] [Related]
53. Complexation of Z-ligustilide with hydroxypropyl-β-cyclodextrin to improve stability and oral bioavailability.
Lu Y; Liu S; Zhao Y; Zhu L; Yu S
Acta Pharm; 2014 Jun; 64(2):211-22. PubMed ID: 24914721
[TBL] [Abstract][Full Text] [Related]
54. Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.
Zhao Y; Sun C; Shi F; Firempong CK; Yu J; Xu X; Zhang W
Pharm Biol; 2016; 54(1):130-8. PubMed ID: 25853954
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and characterization of thiolated β-cyclodextrin as a novel mucoadhesive excipient for intra-oral drug delivery.
Ijaz M; Matuszczak B; Rahmat D; Mahmood A; Bonengel S; Hussain S; Huck CW; Bernkop-Schnürch A
Carbohydr Polym; 2015 Nov; 132():187-95. PubMed ID: 26256340
[TBL] [Abstract][Full Text] [Related]
56. Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration.
Nekkanti V; Karatgi P; Paruchuri S; Pillai R
Drug Deliv; 2011 May; 18(4):294-303. PubMed ID: 21214430
[TBL] [Abstract][Full Text] [Related]
57. Development of an itraconazole-loaded gelatin microcapsule with enhanced oral bioavailability: physicochemical characterization and in-vivo evaluation.
Li DX; Park YJ; Oh DH; Joe KH; Lee JH; Yeo WH; Yong CS; Choi HG
J Pharm Pharmacol; 2010 Apr; 62(4):448-55. PubMed ID: 20604833
[TBL] [Abstract][Full Text] [Related]
58. Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazole.
Merino G; Molina AJ; García JL; Pulido MM; Prieto JG; Alvarez AI
J Pharm Pharmacol; 2003 Jun; 55(6):757-64. PubMed ID: 12841935
[TBL] [Abstract][Full Text] [Related]
59. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
60. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
